Chikungunya virus vaccine (Themis Bioscience)

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameChikungunya virus vaccine (Themis Bioscience)
Drug Alias NameMV-CE3E26KE1MV-CHIKVMV-CHIKMV-CHIK.CE3E26KE1
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoAustria +[4
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThemis Bioscience Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsChikungunya Fever

Other Information

ATC CodeN/A
Related LinksN/A